Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/24 17:03 | 8/9/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | T | 1 | S | -3,807 | 1.08 | 0 | -3,525 | 301 | I | ||||||||||||||||
1/19/24 19:32 | 1/18/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Zakrzewski Joseph S | CA | D | 1 | S | -1,911 | 19.11 | 0 | -100 | 504 | I | ||||||||||||||||
1/18/24 18:19 | 1/16/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Aziz Kabeer | CA | D | 7 | S.m | -3,977 | 17.76 | 0 | -224 | 5,169 | I | ||||||||||||||||
1/18/24 18:18 | 1/16/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Adjuvant Global Health Technology Fund, L.P. | NY | T | 7 | S.m | -3,977 | 17.76 | 0 | -224 | 2,597 | M | ||||||||||||||||
1/17/24 17:03 | 1/12/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Readnour Robin Shane | CA | D | 2 | S | -112 | 21.92 | 0 | -5 | 486 | I | ||||||||||||||||
1/11/24 19:59 | 1/9/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Krause Kevin Michael | CA | O | Chief St | 2 | S.d | -201 | 20.13 | 0 | -10 | 2 | D | |||||||||||||||
1/4/24 18:05 | 1/2/24 | ANTX | Health | Drug | Pharmaceutical Preparations | Easom Eric | CA | DO | CEO | 1 | S | -56 | 20.09 | 0 | -3 | 0 | 1,212 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |